ProQR Therapeutics Statistics
Total Valuation
PRQR has a market cap or net worth of $286.54 million. The enterprise value is $165.69 million.
Important Dates
The next estimated earnings date is Friday, November 7, 2025, before market open.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PRQR has 105.34 million shares outstanding. The number of shares has increased by 20.37% in one year.
| Current Share Class | 105.34M |
| Shares Outstanding | 105.34M |
| Shares Change (YoY) | +20.37% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 1.71% |
| Owned by Institutions (%) | 32.53% |
| Float | 65.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.23 |
| Forward PS | 18.76 |
| PB Ratio | 3.64 |
| P/TBV Ratio | 3.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.76, with a Debt / Equity ratio of 0.25.
| Current Ratio | 3.76 |
| Quick Ratio | 3.69 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -38.87 |
Financial Efficiency
Return on equity (ROE) is -79.47% and return on invested capital (ROIC) is -38.51%.
| Return on Equity (ROE) | -79.47% |
| Return on Assets (ROA) | -20.47% |
| Return on Invested Capital (ROIC) | -38.51% |
| Return on Capital Employed (ROCE) | -40.08% |
| Revenue Per Employee | $121,187 |
| Profits Per Employee | -$280,491 |
| Employee Count | 166 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PRQR has paid $21,139 in taxes.
| Income Tax | 21,139 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.16% in the last 52 weeks. The beta is 0.23, so PRQR's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | -21.16% |
| 50-Day Moving Average | 2.38 |
| 200-Day Moving Average | 2.03 |
| Relative Strength Index (RSI) | 54.87 |
| Average Volume (20 Days) | 623,123 |
Short Selling Information
| Short Interest | 2.09M |
| Short Previous Month | 1.16M |
| Short % of Shares Out | 2.79% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.17 |
Income Statement
In the last 12 months, PRQR had revenue of $20.13 million and -$46.59 million in losses. Loss per share was -$0.48.
| Revenue | 20.13M |
| Gross Profit | 20.13M |
| Operating Income | -49.16M |
| Pretax Income | -46.57M |
| Net Income | -46.59M |
| EBITDA | -48.17M |
| EBIT | -49.16M |
| Loss Per Share | -$0.48 |
Full Income StatementBalance Sheet
The company has $140.65 million in cash and $19.80 million in debt, giving a net cash position of $120.85 million or $1.15 per share.
| Cash & Cash Equivalents | 140.65M |
| Total Debt | 19.80M |
| Net Cash | 120.85M |
| Net Cash Per Share | $1.15 |
| Equity (Book Value) | 78.66M |
| Book Value Per Share | 0.75 |
| Working Capital | 107.09M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$49.56 million and capital expenditures -$873,752, giving a free cash flow of -$49.70 million.
| Operating Cash Flow | -49.56M |
| Capital Expenditures | -873,752 |
| Free Cash Flow | -49.70M |
| FCF Per Share | -$0.47 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -244.24% and -231.45%.
| Gross Margin | 100.00% |
| Operating Margin | -244.24% |
| Pretax Margin | -231.35% |
| Profit Margin | -231.45% |
| EBITDA Margin | -239.31% |
| EBIT Margin | -244.24% |
| FCF Margin | n/a |
Dividends & Yields
PRQR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.37% |
| Shareholder Yield | -20.37% |
| Earnings Yield | -16.26% |
| FCF Yield | -17.34% |
Analyst Forecast
The average price target for PRQR is $8.88, which is 226.47% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.88 |
| Price Target Difference | 226.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 37.64% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PRQR has an Altman Z-Score of -2.95 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.95 |
| Piotroski F-Score | 2 |
